Repository logo
 
Publication

A novel deleterious variant and a founder effect in four new families of MBD4-Associated Neoplasia Syndrome recruited over a period of 20 Years

dc.contributor.authorQuerido, Inês
dc.contributor.authorPinto, Carla
dc.contributor.authorArinto, Patrícia
dc.contributor.authorBrandão, Andreia
dc.contributor.authorSantos, Catarina
dc.contributor.authorPinheiro, Manuela
dc.contributor.authorGuerra, Joana
dc.contributor.authorSilva, João
dc.contributor.authorPeixoto, Ana
dc.contributor.authorTeixeira, Manuel R.
dc.contributor.authorPinto, Carla
dc.date.accessioned2026-01-14T11:55:04Z
dc.date.available2026-01-14T11:55:04Z
dc.date.issued2026-01
dc.description.abstractDNA glycosylases play a crucial role in DNA repair mediated by the base excision repair (BER) pathway, and alterations in these enzymes have been associated with hereditary cancer predisposition. Recently, germline biallelic loss-of-function variants in MBD4 were shown to be responsible for a novel autosomal recessive multi-tumor predisposition syndrome, provisionally denominated as MBD4-associated neoplasia syndrome and characterized by the association of adenomatous polyposis, colorectal cancer, and acute myeloid leukemia (AML). Here, we studied the MBD4 gene in five individuals from four families affected by adenomatous polyposis and AML, who had been referred for genetic counselling at a single institution over a period of approximately 20 years. All patients with this phenotype presented homozygous deleterious germline variants in MBD4, of which one is a founder variant recurrent in three of the families, and another variant has not been previously described in the literature. Our work allowed a molecular diagnosis for these families and significantly contributes to expanding the knowledge about this emerging syndrome caused by MBD4 constitutional deficiency.eng
dc.identifier.citationQuerido, I., Pinto, C., Arinto, P., Brandão, A., Santos, C., Pinheiro, M., Guerra, J., Silva, J., Peixoto, A., & Teixeira, M. R. (2026). A Novel Deleterious Variant and a Founder Effect in Four New Families of MBD4-Associated Neoplasia Syndrome Recruited Over a Period of 20 Years. Clinical Genetics, 109(1), 50–59. https://doi.org/10.1111/cge.70014
dc.identifier.doi10.1111/cge.70014
dc.identifier.eissn1399-0004
dc.identifier.issn0009-9163
dc.identifier.urihttp://hdl.handle.net/10400.22/31516
dc.language.isoeng
dc.peerreviewedyes
dc.publisherWiley
dc.relation.hasversionhttps://onlinelibrary.wiley.com/doi/10.1111/cge.70014
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subjectDNA glycosylases
dc.subjectMUTYH gene
dc.titleA novel deleterious variant and a founder effect in four new families of MBD4-Associated Neoplasia Syndrome recruited over a period of 20 Yearseng
dc.typejournal article
dspace.entity.typePublication
oaire.citation.endPage59
oaire.citation.issue1
oaire.citation.startPage50
oaire.citation.titleClinical Genetics
oaire.citation.volume109
oaire.versionhttp://purl.org/coar/version/c_970fb48d4fbd8a85
person.familyNamePinto
person.givenNameCarla
person.identifier.ciencia-id271F-E46E-86E8
person.identifier.orcid0000-0001-8689-3388
person.identifier.scopus-author-id14523165700
relation.isAuthorOfPublication37633e9b-e29c-4b27-b67f-b593aecd7b77
relation.isAuthorOfPublication.latestForDiscovery37633e9b-e29c-4b27-b67f-b593aecd7b77

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
ART_Carla Pinto.pdf
Size:
2.54 MB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
4.03 KB
Format:
Item-specific license agreed upon to submission
Description: